A Study Evaluating the Efficacy and Safety of HSK3486 for Sedation

NCT04147416 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Sedation

Interventions

DRUG: HSK3486 0.1-0.2 /0.3 mg / kg group
DRUG: Propofol 0.5-1.0/1.5 mg/kg group

Sponsor

Sichuan Haisco Pharmaceutical Group Co., Ltd